Last reviewed · How we verify
Clarithromycin placebo tablets — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Clarithromycin placebo tablets (Clarithromycin placebo tablets) — TenNor Therapeutics (Suzhou) Limited. This is a placebo tablet with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clarithromycin placebo tablets TARGET | Clarithromycin placebo tablets | TenNor Therapeutics (Suzhou) Limited | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clarithromycin placebo tablets CI watch — RSS
- Clarithromycin placebo tablets CI watch — Atom
- Clarithromycin placebo tablets CI watch — JSON
- Clarithromycin placebo tablets alone — RSS
Cite this brief
Drug Landscape (2026). Clarithromycin placebo tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/clarithromycin-placebo-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing